StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) shareholders

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 232M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Waqas Khatri
Joint filing with Ayrton Capital LLC (9.90%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (9.90%)
3,873,6329.90%13G (passive) amendmentDec 31, 2024
Polar Asset Management Partners Inc.2,688,1937.70%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of OCEAValueChange% of portfolio
FNY Investment Advisers, LLC6000.00%$0–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610M0.0%0 / 00 / 00M0M
Q1 202610M0.0%0 / 00 / 00M0M
Q4 202510M0.0%0 / 00 / 00M0M
Q3 202510M0.0%0 / 00 / 50M1M
Q2 202561M0.3%2 / 21 / 191M4M
Q1 2025235M2.0%8 / 54 / 61M0M
Q4 2024214M1.6%4 / 65 / 30M0M
Q3 2024204M1.5%4 / 111 / 180M0M
Q2 2024354M1.7%7 / 1014 / 151M1M
Q1 2024435M2.0%13 / 815 / 51M1M
Q4 2023355M2.2%5 / 148 / 60M1M
Q3 2023386M2.7%5 / 1310 / 20M1M

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Poseidon Bio, LLC
10% owner
Oct 2, 2023Other−500,000––22,342,756
Surendra K. Ajjarapu
Director
Mar 22, 2023Other−1,050,000––315,000
Surendra K. Ajjarapu
Director, 10% owner
Feb 28, 2023Other+21,252––21,252
Aesther Healthcare Sponsor, LLC
10% owner
Feb 28, 2023Other−2,625,000––1,365,000
Aesther Healthcare Sponsor, LLC
10% owner
Feb 28, 2023Other+469,300––469,300
Aesther Healthcare Sponsor, LLC
10% owner
Feb 28, 2023Other+258,200––258,200
Michael L. Peterson
Director
Feb 28, 2023Other+80,000––80,000
Aesther Healthcare Sponsor, LLC
10% owner
Feb 14, 2023Conversion+2,625,000––3,990,000
Aesther Healthcare Sponsor, LLC
10% owner
Feb 14, 2023Other−3,990,000––0
Aesther Healthcare Sponsor, LLC
10% owner
Feb 14, 2023Other+3,990,000––3,990,000
Aesther Healthcare Sponsor, LLC
10% owner
Feb 14, 2023Award+1,365,000––1,365,000
Poseidon Bio, LLC
10% owner
Feb 14, 2023Other+22,842,756––22,842,756
Poseidon Bio, LLC
10% owner
Feb 14, 2023Award+22,842,756$10.00$228.43M22,842,756
Poseidon Bio, LLC
10% owner
Feb 14, 2023Other−456,852––0
Poseidon Bio, LLC
10% owner
Feb 14, 2023Other+456,852––456,852
Poseidon Bio, LLC
10% owner
Feb 14, 2023Other−22,842,756––0
Poseidon Bio, LLC
10% owner
Feb 14, 2023Award+456,852$10.00$4.57M456,852

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.5
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 20 days
53.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ocean Biomedical's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?